Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 1/20 | 0.40 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.40 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.40 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.40 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.40 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.40 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.40 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.40 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.38 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TYR | P14679 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | AURKA | O14965 | 1/20 | 0.32 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14501027 | 0.77 | PIM1 (0.36) | PIM1CSNK1A1CDK5ROCK1DYRK1A | |
| SCHEMBL17287859 | 0.77 | CDK5 (0.48) | PIM1CSNK1A1CDK5ROCK1DYRK1A | |
| SCHEMBL13905621 | 0.77 | BCHE (0.32) | ALDH1A1BCHEACHE | |
| SCHEMBL2972021 | 0.76 | ALDH1A1 (0.44) | PIM1CSNK1A1CDK5ROCK1DYRK1A | |
| SCHEMBL2969601 | 0.74 | NPC1 (0.40) | PIM1CSNK1A1CDK5ROCK1DYRK1A | |
| SCHEMBL2973423 | 0.74 | ALDH1A1 (0.36) | PIM1CSNK1A1CDK5ROCK1DYRK1A | |
| SCHEMBL2965298 | 0.74 | PIM1 (0.34) | PIM1CSNK1A1CDK5ROCK1DYRK1A | |
| SCHEMBL2963720 | 0.72 | ALDH1A1 (0.36) | PIM1CSNK1A1CDK5ROCK1DYRK1A | |
| SCHEMBL2966003 | 0.72 | PIM1 (0.33) | PIM1CSNK1A1CDK5ROCK1DYRK1A | |
| SCHEMBL22810219 | 0.71 | KEAP1 (0.36) | PIM1CSNK1A1CDK5ROCK1DYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8569532-B2 | Catalysts | BOREALIS TECHNOLOGY OY (FI) | 2013-10-29 | — | — | US | disclosed |
| US-8569532-B2 | Catalysts | BOREALIS TECHNOLOGY OY (FI) | 2013-10-29 | — | — | US | disclosed |
| US-20120252993-A1 | CATALYSTS | BOREALIS TECHNOLOGY OY (FI) | 2012-10-04 | — | — | US | disclosed |
| US-20120252993-A1 | CATALYSTS | BOREALIS TECHNOLOGY OY (FI) | 2012-10-04 | — | — | US | disclosed |
| US-20100305286-A1 | CATALYSTS | BOREALIS TECHNOLOGY OY (FI) | 2010-12-02 | — | — | US | disclosed |
| US-20100305286-A1 | CATALYSTS | BOREALIS TECHNOLOGY OY (FI) | 2010-12-02 | — | — | US | disclosed |
| EP-2223944-A1 | Process for producing semicrystalline propylene polymers | Borealis AG (AT) | 2010-09-01 | — | — | EP | disclosed |
| US-7763562-B2 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-07-27 | — | — | US | disclosed |
| US-7667064-B2 | high weight average molecular weight while having a relatively narrow molecular weight distribution, resulting in high strength polyolefin; e.g. dimethylsilandiyl(eta 5-2-methyl-4-bromoinden-1-yl)(N-tert-butylamido)titanium dichloride | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-02-23 | — | — | US | disclosed |
| WO-2009027075-A2 | CATALYSTS | BOREALIS TECHNOLOGY OY (FI) | 2009-03-05 | — | — | WO | disclosed |
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-06-14 | — | — | US | disclosed |
| WO-2006065809-A2 | HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | AP2M1, AP1M1, PYM1 | PIM1 4466/4885CSNK1A1 4303/4885CDK5 2133/4885 |
| US-20120252993-A1 | CATALYSTS | CYP4F11, COXFA4, CYP2F1 | PIM1 2670/4885CSNK1A1 2335/4885CDK5 2199/4885 |
| US-20100305286-A1 | CATALYSTS | H1-2, CCNL2, H1-3 | PIM1 675/4885CSNK1A1 1464/4885CDK5 1045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.